Making Diabetes management Abriiz
Using the very latest in mobile technology and behavioural psychology, medical solutions provider, Ideomed, has expanded their lineup of innovative tools for the effective management of chronic illnesses to include new options to improve compliance for patients with diabetes. The Abriiz Diabetes Management Platform aims to improve the compliance to treatment of the 25.8 million sufferers of the disease in the US alone, who currently report a full compliance rate of only 55%.
The software platform hopes to use customised reminders, social influence and feedback to improve the effectiveness and adherence of current management plans. Ideomed hopes to duplicate their previous success with this current release.
The JMTM staff are excited by this new development in mHealth targeting chronic diseases and hope to publish quality research covering the application of such solutions in the future.
For further information, please see the Ideomed Media Release.